Hangzhou Biotest Biotech Co Ltd (688767) - Total Liabilities

Latest as of March 2026: CN¥121.73 Million CNY ≈ $17.81 Million USD

Based on the latest financial reports, Hangzhou Biotest Biotech Co Ltd (688767) has total liabilities worth CN¥121.73 Million CNY (≈ $17.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Hangzhou Biotest Biotech Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Hangzhou Biotest Biotech Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Hangzhou Biotest Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 688767 financial resilience to evaluate the company's liquid asset resilience ratio.

Hangzhou Biotest Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou Biotest Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Wenzhou Hongfeng Electrical Alloy Co Ltd SHE:300283	China	CN¥2.38 Billion
Beijing SL Pharmaceutical Co Ltd SHE:002038	China	CN¥735.46 Million
First Financial Corporation Indiana NASDAQ:THFF	USA	$5.50 Billion
JOST Werke AG XETRA:JST	Germany	€1.27 Billion
SG Fleet Group Ltd AU:SGF	Australia	AU$2.91 Billion
Zhejiang Hongchang Electrical Technology Co. Ltd. SHE:301008	China	CN¥694.38 Million
Msscorps Co Ltd TW:6830	Taiwan	NT$3.20 Billion
Infund Holding Co Ltd SHE:002141	China	CN¥361.20 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Hangzhou Biotest Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 688767 current and non-current assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	14.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Biotest Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Biotest Biotech Co Ltd (2017–2025)

The table below shows the annual total liabilities of Hangzhou Biotest Biotech Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥168.17 Million ≈ $24.61 Million	-11.39%
2024-12-31	CN¥189.79 Million ≈ $27.77 Million	+19.50%
2023-12-31	CN¥158.82 Million ≈ $23.24 Million	-15.93%
2022-12-31	CN¥188.92 Million ≈ $27.64 Million	-41.58%
2021-12-31	CN¥323.36 Million ≈ $47.32 Million	+69.39%
2020-12-31	CN¥190.89 Million ≈ $27.93 Million	+125.92%
2019-12-31	CN¥84.50 Million ≈ $12.36 Million	+49.60%
2018-12-31	CN¥56.48 Million ≈ $8.27 Million	+17.96%
2017-12-31	CN¥47.88 Million ≈ $7.01 Million	--

About Hangzhou Biotest Biotech Co Ltd

SHG:688767 China Biotechnology

Market Cap

$865.35 Million

CN¥5.91 Billion CNY

Market Cap Rank

#9521 Global

#2422 in China

Share Price

CN¥39.60

Change (1 day)

-1.93%

52-Week Range

CN¥30.56 - CN¥48.37

All Time High

CN¥125.45